Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stan Kaye

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Cancer Chemotherapy and Pharmacology|June 27, 2003
A phase I study of ZD0473 combined with paclitaxel for the treatment of solid malignanciesChris Twelves, Martin Reck, Alan Anthoney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
The dl1520 virus is found preferentially in tumor tissue after direct intratumoral injection in oral carcinomaStephen Morley, Gordon MacDonald, David Kirn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
HDAC inhibitors and cardiac safetyRhoda Molife, Peter Fong, Michelle Scurr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
A phase Ib and pharmacokinetic trial of patupilone combined with carboplatin in patients with advanced cancerMartin Forster, Stan Kaye, Amit Oza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
The dl1520 virus is found preferentially in tumor tissue after direct intratumoral injection in oral carcinomaScott Wadler, Howard Kaufman, Marshall Horwitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Prospective validation of a prognostic score to improve patient selection for oncology phase I trialsHendrik-Tobias Arkenau, Jorge Barriuso, David Olmos, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2008
Identification of factors limiting patient recruitment into phase I trials: a study from the Royal Marsden HospitalVasilios Karavasilis, Laurence Digue, Tobias Arkenau, et al.
BMC Cancer|July 2, 2017
The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozoleAngela George, Jennifer McLachlan, Nina Tunariu, et al.
European Journal of Cancer (Oxford, England : 1990)|December 14, 2011
Pitfalls and limitations of a single-centre, retrospectively derived prognostic score for phase I oncology trial participants - reply to Fussenich et al.: a new, simple and objective prognostic score for phase I cancer patientsDavid Olmos, Joo Ern Ang, Carlos Gomez-Roca, et al.
Journal of Oncology|July 21, 2011
Perceptions and referral trends into phase I oncology trials: results of a clinical surveyAndre Brunetto, David Olmos, Hendrik-Tobias Arkenau, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Cancer Chemotherapy and Pharmacology|June 27, 2003
A phase I study of ZD0473 combined with paclitaxel for the treatment of solid malignanciesChris Twelves, Martin Reck, Alan Anthoney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
The dl1520 virus is found preferentially in tumor tissue after direct intratumoral injection in oral carcinomaStephen Morley, Gordon MacDonald, David Kirn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
HDAC inhibitors and cardiac safetyRhoda Molife, Peter Fong, Michelle Scurr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
A phase Ib and pharmacokinetic trial of patupilone combined with carboplatin in patients with advanced cancerMartin Forster, Stan Kaye, Amit Oza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
The dl1520 virus is found preferentially in tumor tissue after direct intratumoral injection in oral carcinomaScott Wadler, Howard Kaufman, Marshall Horwitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Prospective validation of a prognostic score to improve patient selection for oncology phase I trialsHendrik-Tobias Arkenau, Jorge Barriuso, David Olmos, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2008
Identification of factors limiting patient recruitment into phase I trials: a study from the Royal Marsden HospitalVasilios Karavasilis, Laurence Digue, Tobias Arkenau, et al.
BMC Cancer|July 2, 2017
The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozoleAngela George, Jennifer McLachlan, Nina Tunariu, et al.
European Journal of Cancer (Oxford, England : 1990)|December 14, 2011
Pitfalls and limitations of a single-centre, retrospectively derived prognostic score for phase I oncology trial participants - reply to Fussenich et al.: a new, simple and objective prognostic score for phase I cancer patientsDavid Olmos, Joo Ern Ang, Carlos Gomez-Roca, et al.
Journal of Oncology|July 21, 2011
Perceptions and referral trends into phase I oncology trials: results of a clinical surveyAndre Brunetto, David Olmos, Hendrik-Tobias Arkenau, et al.
Pageof 5